BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13549548)

  • 1. The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients.
    ADAMS DD
    J Clin Endocrinol Metab; 1958 Jul; 18(7):699-712. PubMed ID: 13549548
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the thyroid-stimulating hormone content of serum from thyrotoxic and euthyroid people.
    Adams DD; Kennedy TH; Purves HD
    J Clin Endocrinol Metab; 1969 Jul; 29(7):900-3. PubMed ID: 5793449
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cases of hyperthyroidism with an increase of serum thyrotropic hormone].
    FOLDES J; REV J; HERMANN R
    Orv Hetil; 1961 Apr; 102():731-3. PubMed ID: 13700501
    [No Abstract]   [Full Text] [Related]  

  • 4. Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism.
    Sawin CT; Geller A; Kaplan MM; Bacharach P; Wilson PW; Hershman JM
    Arch Intern Med; 1991 Jan; 151(1):165-8. PubMed ID: 1985591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyrotropic hormone and the thyroid gland (present status)].
    Kalinin AP; Izmaĭlov GI
    Ter Arkh; 1977; 49(12):131-7. PubMed ID: 414369
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperthyroidism in Tasmania following iodide supplementation: measurements of thyroid-stimulating autoantibodies and thyrotropin.
    Adams DD; Kennedy TH; Stewart JC; Utiger RD; Vidor GI
    J Clin Endocrinol Metab; 1975 Aug; 41(2):221-8. PubMed ID: 51028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid stimulating hormone in the serum as the first test in thyrotoxicosis].
    Kirkegaard BC; Bech K; Bregengård C; Faber J; Feldt-Rasmussen U
    Ugeskr Laeger; 1986 Apr; 148(15):897-9. PubMed ID: 3705233
    [No Abstract]   [Full Text] [Related]  

  • 8. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism.
    Martino E; Pinchera A; Capiferri R; Macchia E; Sardano G; Bartalena L; Mazzanti F; Baschieri L
    J Clin Endocrinol Metab; 1976 Sep; 43(3):543-9. PubMed ID: 821960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of thyrotropic function of the pituitary in pathogenesis of thyrotoxicosis].
    LIVERGANT IuE
    Probl Endokrinol Gormonoter; 1956; 2(4):32-41. PubMed ID: 13379296
    [No Abstract]   [Full Text] [Related]  

  • 10. ["Long-acting thyroid stimulator" and thyrotropic hormone in thyrotoxicosis in newborn infants].
    Gautier E; Juillard E; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Jan; 98(1):8-12. PubMed ID: 5695264
    [No Abstract]   [Full Text] [Related]  

  • 11. Levels of serum thyroid-stimulating hormone in hyperthyroidism.
    Smith SR; Burton DW; Izenstark JL
    Arch Intern Med; 1979 Jul; 139(7):757-60. PubMed ID: 454062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of synthetic "thyrotropin-releasing factor" on plasma levels of thyrotropin and growth hormone in healthy subjects and patients with hyperthyroidism or primary hypothyroidism.
    zur Mühlen A von ; Hesch RD; Emrich D; Creutzfeldt W
    Ger Med Mon; 1971; 1(1):1-2. PubMed ID: 4103049
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical and subclinical thyroid disorders associated with pernicious anemia. Observations on abnormal thyroid-stimulating hormone levels and on a possible association of blood group O with hyperthyroidism.
    Carmel R; Spencer CA
    Arch Intern Med; 1982 Aug; 142(8):1465-9. PubMed ID: 7103627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical hyperthyroidism: controversies in management.
    Shrier DK; Burman KD
    Am Fam Physician; 2002 Feb; 65(3):431-8. PubMed ID: 11858626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of commercial kits for estimation of thyroid stimulating hormone (TSH).
    Henley R; Kisgyorgy D
    Med Lab Sci; 1979; 36(4):381-2. PubMed ID: 522623
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurements of the thyroid-stimulating hormone content of serum from hypothyroid and euthyroid people.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1968 Mar; 28(3):325-31. PubMed ID: 5642686
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on the determination of thyrotropic hormone in guinea pigs. Human blood serum as a factor lowering thyrotropic hormone activity].
    FOLDES J; NAGY J
    Magy Belorv Arch (1955); 1962 Jun; 15():94-8. PubMed ID: 13893805
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of LATS and TSH in the blood.
    Lemarchand-Béraud T; Griessen M; Scazziga BR
    Ann Clin Res; 1972 Jun; 4(3):121-37. PubMed ID: 4625026
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyrotropin secretion in thyrotoxic and thyroxine-treated patients: assessment by a sensitive immunoenzymometric assay.
    Spencer CA; Lai-Rosenfeld AO; Guttler RB; LoPresti J; Marcus AO; Nimalasuriya A; Eigen A; Doss RC; Green BJ; Nicoloff JT
    J Clin Endocrinol Metab; 1986 Aug; 63(2):349-55. PubMed ID: 3088021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.